Finch Therapeutics Alternatives & Competitors

12 companies similar to Finch Therapeutics

Abivax

90 Post-IPO Debt $376.20M

Paris, France

Biotechnology Health Care +1

HMNC Brain Health

Transforming Therapy of Depression and Anxiety 🧬

29 $25.30M

Germany

Biotechnology Health Care +3

Sentien Biotechnologies, Inc.

Restoring Balance to the Immune System

5 Series A $15.13M

Biotechnology Health Care +1

Pinteon Therapeutics

Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...

2-10 Series B $51.60M

Biotechnology Health Care +1

Track all Finch Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Perceiv

Pioneering the digital infrastructure for modern neurological care.

6 Seed $1.99M

Montreal, Canada

AI Analytics +4

Phylagen

Harnessing microbial data with AI for industry-leading insights through DNA sequencing and...

Series A $14.00M

AI Big Data +4

Rani Therapeutics

Making Oral Biologics a Reality.

96 Post-IPO Equity $266.50M

San Jose, United States

Biotechnology Health and Wellness +1

Aspen Neuroscience, Inc.

Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...

128 Series C $387.00M

La Jolla, United States

Biotechnology Health and Wellness +1

Resilient Biotics

Harnessing the power of the respiratory microbiome

13 Series A $7.17M

Durham, United States

Analytics Biotechnology +1

Tempus AI

Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advanc...

3157 Post-IPO Debt $1.64B

Chicago, United States

AI Biotechnology +2

Odimma Therapeutics

Empowering Personalized Immunotherapy to Treat Cancer

6 Seed $2.00M

France

Biotechnology Health Care +2

Acer Therapeutics Inc.

Focused on the acquisition, development & commercialization of therapies for serious rare...

16 Post-IPO Debt $116.95M

Newton, United States

Biotechnology Health and Wellness +1

About Finch Therapeutics

Finch Therapeutics is a biotechnology company founded in 2017, specializing in microbiome assets. Its flagship product, CP101, displayed promising clinical trial results in treating recurrent C. difficile infection.

Taxonomy

Microbiome Therapeutics, Microbial Therapies, Intellectual Property, Clinical Data Analysis, Machine Learning Algorithms, Biopharmaceuticals, Fecal Transplantations, CDI Treatment, Biotech Startups, Microbiome Engineering, Patient-centric Approach

Frequently Asked Questions

Companies similar to Finch Therapeutics include Abivax, HMNC Brain Health, Sentien Biotechnologies, Inc., Pinteon Therapeutics, Perceiv. They work in Biotechnology and Health and Wellness and share Finch Therapeutics's focus on biopharmaceuticals, biotech startups and machine learning algorithms.

Bounce Watch lists 12 companies that share Finch Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Finch Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Finch Therapeutics Profile Abivax Alternatives HMNC Brain Health Alternatives Sentien Biotechnologies, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Finch Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.